$0.9478
At close: May 5 EDT
$0.9420
-0.00580-0.61%
Pre-Market: 4:19 AM EDT
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
I-MAB Stock Price, Quotes and Forecasts | NASDAQ:IMAB | Benzinga
Explore I-MAB stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IMAB.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy I-MAB (IMAB) stock?
You can purchase shares of I-MAB (NASDAQ:IMAB) through any online brokerage.
Who are I-MAB (IMAB) competitors?
Other companies in I-MAB’s space includes: Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Whitehawk Therapeutics (NASDAQ:WHWK).
What is the forecast, or price target, for I-MAB (IMAB) stock?
I-MAB has a consensus price target of $11.50.
What is the current price for I-MAB (IMAB)?
The stock price for I-MAB (NASDAQ: IMAB) is $0.942 last updated May 5, 2025 at 4:19 AM EDT.
Does I-MAB (IMAB) pay a dividend?
There are no upcoming dividends for I-MAB.
When is I-MAB (NASDAQ:IMAB) reporting earnings?
I-MAB’s FY earnings are confirmed for Thursday, April 3, 2025.
Is I-MAB (IMAB) going to split?
There is no upcoming split for I-MAB.
What sector and industry does I-MAB (IMAB) operate in?
I-MAB is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
